Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608764 · ClinicalTrials.gov registry record
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial of Pulmonary Disease, Chronic Obstructive and Emphysema, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 10,718
- Enrollment target
- 20
- Study locations
NCT00608764 is a study of Pulmonary Disease, Chronic Obstructive and Emphysema that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 10,718 participants, above the 899-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (1092% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT00608764, a study of Pulmonary Disease, Chronic Obstructive and Emphysema, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 10,718 participants
- Enrollment target
- 20
- Study locations
Study Summary
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.
Conditions Studied
Study Locations (20)
Minnesota
- Minneapolis VA Medical Center - Minneapolis
- HealthPartners Research Foundation - Minneapolis
- University of Minnesota - Minneapolis
California
- University of California at San Diego - San Diego
- Los Angeles Biomedical Research Institute - Torrance
Massachusetts
- Brigham and Women's Hospital - Boston
- Reliant Medical Group - Worcester
Michigan
- Ann Arbor VA Medical Center - Ann Arbor
- University of Michigan - Ann Arbor
Pennsylvania
- Temple University - Philadelphia
- University of Pittsburgh - Pittsburgh
Texas
- Baylor College of Medicine - Houston
- University of Texas Health Sciences Center at San Antonio - San Antonio
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,718 participants |
| Start Date | 2007-11 |
| Est. Completion | 2028-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608764
The ClinicalTrials.gov registry entry for NCT00608764 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 10,718 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 899-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (1092% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 0 interventions.
NCT00608764 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Minnesota, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00608764 about?
NCT00608764 is a clinical study titled "Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)". Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.
What is the current status of trial NCT00608764?
This trial is currently active not recruiting. The enrollment target is 10,718 participants. The study started on 2007-11. Estimated completion is 2028-08.
What conditions does trial NCT00608764 study?
This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive, Emphysema, Bronchitis, Chronic.
Who is sponsoring clinical trial NCT00608764?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00608764 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease, Chronic Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RECRUITING · Phase 3
-
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 1
-
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
RECRUITING · NA
-
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RECRUITING · Phase 3
-
Trial to Determine Effective Aspirin Dose in COPD
RECRUITING · Phase 3
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.